Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-1.0%
5Y CAGR+25.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-1.0%/yr
Annual compound
5Y CAGR
+25.0%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $33.87M | +17.0% |
| 2024 | $28.95M | -3.6% |
| 2023 | $30.05M | -13.8% |
| 2022 | $34.87M | -15.6% |
| 2021 | $41.32M | +272.3% |
| 2020 | $11.10M | +8571.9% |
| 2019 | $128000.00 | - |